Genenta Science S.p.A.
GNTA
$1.60
-$0.20-11.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.89% | 13.56% | 2.00% | 15.20% | 23.43% |
| Total Depreciation and Amortization | -34.10% | -25.79% | -16.17% | -6.87% | 4.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.65% | 58.82% | 90.19% | 43.78% | 11.70% |
| Change in Net Operating Assets | -190.43% | -188.41% | -186.95% | -120.57% | 513.08% |
| Cash from Operations | -12.69% | -39.79% | -71.73% | 6.87% | 44.26% |
| Capital Expenditure | -72.92% | -136.59% | -226.47% | 15.22% | 67.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -323.30% | -372.55% | -217.83% | 133.17% | 146.31% |
| Cash from Investing | -323.56% | -373.17% | -217.89% | 133.04% | 146.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5,360.64% | 3,176.36% | 996.90% | 1,094.04% | 45,033.33% |
| Cash from Financing | 8,518.89% | 6,164.72% | 3,805.28% | 3,733.67% | 48,700.00% |
| Foreign Exchange rate Adjustments | 404.35% | 393.15% | 382.23% | 229.68% | -272.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.46% | 99.99% | 83.32% | 99.53% | 103.40% |